Plain-English translation of NCT01762813 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This is a research study that collects blood samples and tumor tissue from patients undergoing surgery for colorectal cancer. Researchers will analyze these samples to understand the genetic and molecular features of each person's cancer. Over time, the study will also ask patients about their experiences and health outcomes to see how these relate to the cancer's characteristics.
Colorectal cancer varies greatly from person to person, and doctors need better ways to predict which treatments will work best for each patient. By studying the molecular makeup of tumors alongside patient outcomes, researchers hope to develop more personalized approaches to treating this disease.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would donate a blood sample and allow researchers to collect a sample of your tumor tissue during your planned cancer surgery. The study will follow your clinical outcomes and may also ask you to complete surveys about your health and experiences. Your samples will be analyzed to understand your cancer's characteristics, and this information may help guide your treatment and improve care for future patients.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Norway
Helse Stavanger HF
Enrollment target
~1,200 participants
Started
January 2013
Primary completion
December 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ramesh L. Kajavi, RN
Helse Stavanger HF
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.